|
Conclusion: the manufacturing processes, associated controls and inspections were reviewed to determine the root cause for the reported event.Several potential causes were reviewed to confirm what created the event and not detected the issue prior the releasing of the material from the manufacturing lines.Dhr was reviewed and no anomalies were detected during the manufacturing of this order or coating of the affected component.Handling for the reported component during manufacturing was reviewed to verify if it could be damaged, however there is no hard manipulation or overhandling that may cause damage to the component during manufacturing.The assembly of this component is performed manually therefore, tooling could not be a source of damage since there were none involved.Layering configuration was reviewed to verify if this could lead to the reported non-conformance however there was no direct stress on this component caused by the configuration or other components.Dhr review showed progressive inspection and qa inspection were completed with no issues for this manufacturing work order.It was confirmed this defect could not have been originated during manufacturing of the custom pack.Notification to manufacturing personnel was performed to spread awareness on this component.Trends for issues with this product are reviewed monthly according to the trend procedure.This regulatory report is being submitted as part of a retrospective review and remediation per d00953163 as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|